Literature DB >> 31860207

The Contribution of Mitochondrial Ion Channels to Cancer Development and Progression.

Magdalena Bachmann1, Giovanna Pontarin1, Ildiko Szabo2,3.   

Abstract

Mitochondria play a central role in cancer development, by contributing to most of the classical hallmarks of cancer, including sustained proliferation, metabolic re-programming, apoptosis resistance, invasion and induction of angiogenesis [1]. In addition, mitochondria affect also the function of anti- and pro-tumoral immune cells in the tumor microenvironment. Mitochondria harbor a plethora of regulated ion channels whose function is related to ion/ metabolite transport and to fine-tuning of mitochondrial membrane potential as well as of reactive oxygen species release. As a consequence, growing evidence link ion channels located both in the outer and inner mitochondrial membranes to several cancer hallmarks. The present review summarizes our recent knowledge about the participation and role of mitochondrial channels leading to acquisition of cancer hallmarks and thus to cancer progression. © Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Entities:  

Keywords:  Cancer hallmarks; Mitochondrial ion channels; Modulation of mitochondrial function; Modulation of hallmark capabilities by ion channel modulators

Mesh:

Substances:

Year:  2019        PMID: 31860207     DOI: 10.33594/000000198

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

Review 1.  Insights Into the Role of Mitochondrial Ion Channels in Inflammatory Response.

Authors:  Devasena Ponnalagu; Harpreet Singh
Journal:  Front Physiol       Date:  2020-04-09       Impact factor: 4.566

Review 2.  Mitochondrial Ion Channels of the Inner Membrane and Their Regulation in Cell Death Signaling.

Authors:  Andrea Urbani; Elena Prosdocimi; Andrea Carrer; Vanessa Checchetto; Ildikò Szabò
Journal:  Front Cell Dev Biol       Date:  2021-01-05

Review 3.  Revisiting Mitochondria Scored Cancer Progression and Metastasis.

Authors:  Rohit Gundamaraju; Wenying Lu; Rishya Manikam
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

Review 4.  Alternative Targets for Modulators of Mitochondrial Potassium Channels.

Authors:  Antoni Wrzosek; Shur Gałecka; Monika Żochowska; Anna Olszewska; Bogusz Kulawiak
Journal:  Molecules       Date:  2022-01-04       Impact factor: 4.411

5.  Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model.

Authors:  Filippo Severin; Andrea Urbani; Tatiana Varanita; Magdalena Bachmann; Michele Azzolini; Veronica Martini; Marco Pizzi; Angelo Paolo Dei Tos; Federica Frezzato; Andrea Mattarei; Paolo Ghia; Maria Teresa Sabrina Bertilaccio; Erich Gulbins; Cristina Paradisi; Mario Zoratti; Gianpietro Carlo Semenzato; Luigi Leanza; Livio Trentin; Ildiko Szabò
Journal:  J Exp Clin Cancer Res       Date:  2022-02-16

6.  Functional expression of mitochondrial KCa3.1 channels in non-small cell lung cancer cells.

Authors:  Etmar Bulk; Luca Matteo Todesca; Magdalena Bachmann; Ildiko Szabo; Marius Rieke; Albrecht Schwab
Journal:  Pflugers Arch       Date:  2022-09-24       Impact factor: 4.458

7.  Using Liposomes to Alleviate the Toxicity of Chelerythrine, a Natural PKC Inhibitor, in Treating Non-Small Cell Lung Cancer.

Authors:  Jiahui Wang; Yijie Song; Ning Zhang; Ning Li; Congying Liu; Bing Wang
Journal:  Front Oncol       Date:  2021-05-27       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.